Defining the clinically meaningful difference in gait speed in persons with Parkinson disease

Journal of Neurologic Physical Therapy

Volumn 38, Issue 4, 2014, Pages 233-238

  Hass, Chris J ^a   Bishop, Mark ^a   Moscovich, Mariana ^a   Stegemöller, Elizabeth L ^b   Skinner, Jared ^a   Malaty, Irene A ^a   Shukla, Aparna Wagle ^a   McFarland, Nikolaus ^a   Okun, Michael S ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b IOWA STATE UNIVERSITY   (United States)

Author keywords

Locomotion; Meaningful improvement; Parkinson; Walking

Indexed keywords

AGED; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; GAIT; HUMAN; MALE; MIDDLE AGED; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; WALKING;

ACTIVITIES OF DAILY LIVING; AGED; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; GAIT; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME; WALKING;

EID: 84913584914     PISSN: 15570576     EISSN: 15570584     Source Type: Journal    
DOI: 10.1097/NPT.0000000000000055     Document Type: Article

References (49)

1. Stewart KC, Fernandez HH, Okun MS, Jacobson CE, Hass CJ. Distribution of motor impairment influences quality of life in Parkinson's disease. Mov Disord. 2008;23(10):1466-1468.
2. Ellis T, Motl RW. Physical activity behavior change in persons with neurologic disorders: overview and examples from Parkinson disease and multiple sclerosis. J Neurol Phys Ther. 2013;37(2):85-90.
3. Lo RY, Tanner CM, Albers KB, et al. Clinical features in early Parkinson disease and survival. Arch Neurol. 2009;66(11):1353-1358.
4. Nisenzon AN, Robinson ME, Bowers D, Banou E, Malaty I, Okun MS. Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? Parkinsonism Relat Disord. 2011;17(2):89-94.
5. AndrewsAW, Chinworth SA, Bourassa M, Garvin M, Benton D, Tanner S. Update on distance and velocity requirements for community ambulation. J Geriatr Phys Ther. 2010;33(3):128-134.
6. Friedman PJ, Richmond DE, Baskett JJ. A prospective trial of serial gait speed as a measure of rehabilitation in the elderly. Age Aging. 1988;17(4):227-235.
7. Rabadi MH, Blau A. Admission ambulation velocity predicts length of stay and discharge disposition following stroke in an acute rehabilitation hospital. Neurorehabil Neural Repair. 2005;19(1):20-26.
8. White DK, Neogi T, Nevitt MC, et al. Trajectories of gait speed predict mortality in well-functioning older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2013;68(4): 456-464.
9. Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc. 2003;51(3):314-322.
10. Vieregge P, Stolze H, Klein C, Heberlein I. Gait quantification in Parkinson's disease-locomotor disability and correlation to clinical rating scales. J Neural Transm. 1997;104:237-248.
11. Tan D, Danoudis M, McGinley J, Morris ME. Relationships between motor aspects of gait impairments and activity limitations in people with Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2012;18(2):117-124.
12. Brusse KJ, Zimdars S, Zalewski KR, Steffen TM. Testing functional performance in people with Parkinson disease. Phys Ther. 2005;85(2):134-141.
13. Lim LI, van Wegen EE, de Goede CJ, et al. Measuring gait and gaitrelated activities in Parkinson's patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord. 2005;11(1):19-24.
14. Morris ME, Matyas TA, Iansek R, Summers JJ. Temporal stability of gait in Parkinson's disease. Phys Ther. 1996;76(7):763-777; discussion 778-780.
15. Elbers RG, van Wegen EE, Verhoef J, Kwakkel G. Is gait speed a valid measure to predict community ambulation in patients with Parkinson's disease? J Rehabil Med. 2013;45(4):370-375.
16. Beaton DE, Bombardier C, Katz JN, Wright JG. A taxonomy for responsiveness. J Clin Epidemiol. 2001;54(12):1204-1217.
17. Hass CJ, Buckley TA, Pitsikoulis C, Barthelemy EJ. Progressive resistance training improves gait initiation in individuals with Parkinson's disease. Gait Posture. 2012;35(4):669-673.
18. Norman GR, Sridhar FG, Guyatt GH, Walter SD. The relation of distribution- and anchor-based approaches in interpretation of changes in health related quality of life. Med Care. 2001;39:1039-1047.
19. Tilson JK, Sullivan KJ, Cen SY, et al. Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther. 2010;90(2):196-208.
20. Kesar TM, Binder-Macleod SA, Hicks GE, Reisman DS. Minimal detectable change for gait variables collected during treadmill walking in individuals post-stroke. Gait Posture. 2011;33(2):314-317.
21. Hollman JH, Beckman BA, Brandt RA, Merriwether EN, Williams RT, Nordrum JT. Minimum detectable change in gait velocity during acute rehabilitation following hip fracture. J Geriatr Phys Ther. 2008;31(2):53-56.
22. Steffen T, Seney M. Test-retest reliability and minimal detectable change on balance and ambulation tests, the 36-item Short-Form Health Survey, and the Unified Parkinson Disease Rating Scale in people with parkinsonism. Phys Ther. 2008;88(6):733-746.
23. Kwon S, Perera S, Pahor M, et al. What is a meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study). J Nutr Health Aging. 2009;13(6):538-544.
24. Hass CJ, Malczak P, Nocera J, et al. Quantitative normative gait data in a large cohort of ambulatory persons with Parkinson's disease. PLoS One. 2012;7(8):e42337.
25. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L (2004). "Movement Disorder Society Task Force Report on the Hoehn and Yahr Staging Scale: Status and Recommendations. The Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease." Movement Disorders 19(9):1020-1028. doi: 10.1002/mds.20213.PMID 15372591
26. Schwab JF, England AC. Projection Technique for Evaluating Surgery in Parkinson's Disease. In: Billingham FH, Donaldson MC, eds. Third Symposium on Parkinson's Disease. Livingstone, Edinburgh; 1969: 152-157.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.
28. Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ. The clinically important difference on the Unified Parkinson's Disease Rating Scale. Arch Neurol. 2010;67(1): 64-70.
29. Perera S, Mody SH, Woodman RC, Studenski SA. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc. 2006;54(5):743-749.
30. Tomlinson CL, Patel S, Meek C, et al. Physiotherapy versus placebo or no intervention in Parkinson's disease. Cochrane Database Syst Rev. 2012;8:CD002817.
31. Shulman LM, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. Arch Neurol. 2012:1-8.
32. Li F, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med. 2012;366(6): 511-519.
33. Alon G, Yungher DA, Shulman LM, Rogers MW. Safety and immediate effect of noninvasive transcranial pulsed current stimulation on gait and balance in Parkinson disease. Neurorehabil Neural Repair. 2012;26(9):1089-1095.
34. Cavanaugh JT, Ellis TD, Earhart GM, FordMP, Foreman KB, Dibble LE. Capturing ambulatory activity decline in Parkinson's disease. J Neurol Phys Ther. 2012;36(2):51-57.
35. Bryant MS, Rintala DH, Hou JG, Lai EC, Protas EJ. Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease. NeuroRehabilitation. 2011;29(3):247-252.
36. Moore ST, MacDougall HG, Gracies JM, Ondo WG. Locomotor response to levodopa in fluctuating Parkinson's disease. Exp Brain Res. 2008;184(4):469-478.
37. Morris M, Iansek R, McGinley J, Matyas T, Huxham F. Threedimensional gait biomechanics in Parkinson's disease: evidence for a centrally mediated amplitude regulation disorder. Mov Disord. 2005;20(1): 40-50.
38. Shan DE, Lee SJ, Chao LY, Yeh SI. Gait analysis in advanced Parkinson's disease-effect of levodopa and tolcapone. Can J Neurol Sci. 2001;28(1):70-75.
39. Carpinella I, Crenna P, Marzegan A, et al. Effect of L-dopa and subthalamic nucleus stimulation on arm and leg swing during gait in Parkinson's disease. Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6665-6668.
40. Chastan N, Westby GW, Yelnik J, et al. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease. Brain. 2009;132(Pt 1):172-184.
41. Fasano A, Romito LM, Daniele A, et al. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants. Brain. 2010;133(9):2664-2676.
42. Ferrarin M, Rizzone M, Bergamasco B, et al. Effects of bilateral subthalamic stimulation on gait kinematics and kinetics in Parkinson's disease. Exp Brain Res. 2005;160(4):517-527.
43. Kelly VE, Israel SM, Samii A, Slimp JC, Goodkin R, Shumway-Cook A. Assessing the effects of subthalamic nucleus stimulation on gait and mobility in peoplewith Parkinson disease. Disabil Rehabil. 2010;32(11):929-936.
44. Liu W, McIntire K, Kim SH, et al. Quantitative assessments of the effect of bilateral subthalamic stimulation on multiple aspects of sensorimotor function for patients with Parkinson's disease. Parkinsonism Relat Disord. 2005;11(8):503-508.
45. Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Mov Disord. 2003;18(9):1000-1007.
46. Faist M, Xie J, Kurz D, et al. Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain. 2001;124(Pt 8):1590-1600.
47. Barthuly AM, Bohannon RW, Gorack W. Gait speed is a responsive measure of physical performance for patients undergoing short-term rehabilitation. Gait Posture. 2012;36(1):61-64.
48. Palombaro KM, Craik RL, Mangione KK, Tomlinson JD. Determining meaningful changes in gait speed after hip fracture. Phys Ther. 2006;86(6):809-816.
49. Rolland YM, Cesari M, Miller ME, Penninx BW, Atkinson HH, Pahor M. Reliability of the 400-m usual-pace walk test as an assessment of mobility limitation in older adults. J Am Geriatr Soc. 2004;52(6):972-976.